Novus Biologicals Ranked in the Inc. 5000 - Inc. Magazine's List of America's Fastest-Growing Private Companies

Today, August 26th, Inc. magazine ranked Novus Biologicals no.2647 on its fourth annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies.  The list represents the most comprehensive look at the most important segment of the economy - America's independent-minded entrepreneurs.

"We are thrilled and honored to be recognized as one of America's fastest growing companies," states Novus Biologicals' President and CEO, Karen Padgett.  "To be recognized for four consecutive years is a testament to our dedication to our customers, employees and the industry."

Novus Biologicals develops and markets antibodies used by scientific researchers in government, university, and biotech labs worldwide.  In addition to their line of antibodies, Novus also provides peptides, proteins, lysates, antibody labeling kits, and additional support products to the bioscience industry.  Novus' 3-year growth is 88%, ranking them at no.219 in the Health industry and no.51 in the Denver-metro area.  Novus has made the Inc. 5000 list four years in a row, increasing their rank each year (no. 3362 in 2007, no. 3062 in 2008, no. 2807 in 2009).

The 2010 Inc. 500 | 5000 is ranked according to percentage revenue growth when comparing 2006 to 2009.  To qualify, companies must have been founded and generating revenue by June 30, 2006.  Additionally, they had to be based in the United States, privately held, for profit, and independent - not subsidiaries or divisions of other companies - as of December 31, 2009.



For more information on Novus' ranking in the Inc. 5000 or for media requests, please contact

Release Date: 
Thursday, August 26, 2010 - 06:00